Find Simple Methods to Prevent Heart Attacks and Stroke
12,000 patients who come from 21 countries have been studied by the Population Health Research Institute regarding drugs that can stop CVD and many of the strokes and heart attacks they lead to.
12,000 patients who come from 21 countries have been studied by the Population Health Research Institute regarding drugs that can stop CVD and many of the strokes and heart attacks they lead to. Out of the 50 million suffered, around 18million die.
Dr. Salim Yusuf said that with just 10% of those already at risk being helped, it could mean a better outlook for up to 30 million people. There have been three methods followed, and this includes two types of therapy. Statins that can lower cholesterol and blood pressure drugs known as antihypertensives are used and also a combination of the two.
READ ALSO: Heart Disease Could be Limited With This New Drug
The studies are recorded as Hope-3 and are produced in the New England Journal of Medicine and covered those at risk rather than those already diagnosed. Statins improved 25% of patients while antihypertensives did not have as much of an effect on CVD patients, but showed some improvement for those with hypertension. Another 5% was added when both worked together.
Along with Dr. Yusuf was Dr. Eva Lonn and Lonn stated that the trials cleared up how to best manage cholesterol and blood pressure. It means that a solution can be brought to more people worldwide who were already at risk.
Countries who find antihypertensives and statins inexpensive will consider the findings of Hope-3 promising but certain parts of the world will still be pried out. The hope is that the prices continue to drop and will do so more and more as they are used more widely.
Source; Mcmaster.ca / eurekalert.org
Feature Photo; ShutterStock
Related Coverage
- The Use of Search Engines to Help Diagnose Patients With Medical Conditions Could Soon Be Coming Our Way
- The Trouble With Growing Your Own DDoS Protection Methods
- Scientists Created The Most Efficient Solar Cells Ever
- Who Will Replace Uber and Lyft in Austin?
- New Grant Allocated to Imperial College Professor to Research Incurable Lung Disease
Don't miss new tech stories on Google
Add TrendinTech once in the Google app and our stories appear in your news suggestions.
Rachel Kowalski
Rachel Kowalski is the Cybersecurity Analyst at TrendinTech, where she covers vulnerabilities, ransomware, supply chain attacks, nation-state operations and the security rules shaping organizations in the United States and Europe. Before moving into journalism she worked as a threat intelligence analyst at a security vendor and later reported for CyberScoop and the security desk at Wired, covering the SolarWinds compromise and the ransomware wave that hit hospitals and pipelines. Rachel holds a Master of Science in Cybersecurity from the Georgia Institute of Technology and attends Black Hat and DEF CON in Las Vegas each year, where she follows research from the security community. She writes to make risks and countermeasures understandable to people who are not specialists.
All stories by Rachel Kowalski (214)